PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript May 14, 2025
PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.25.
Operator: Greetings, and welcome to the PDS Biotech’s First Quarter 2025 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, Mike Moyer of LifeSci Advisors. Thank you, sir. You may begin.
Mike Moyer: Thank you, operator. Good morning, everyone, and...
